E-LIB Suche - Ergebnisse für: Yoo, Young-Suk

1

Dual targeting of RIG-I and MAVS by MARCH5 mitochondria ubi..:

Park, Yeon-Ji ; Oanh, Nguyen Thi Kim ; Heo, June...
Cellular Signalling. 67 (2020) - p. 109520 , 2020

Link: https://doi.org/10.1016/..

2

Mitochondria ubiquitin ligase, MARCH5 resolves hepatitis B ..:

Yoo, Young-Suk ; Park, Yeon-Ji ; Lee, Ho-Soo...
Cell Death & Disease. 10 (2019) 12 - p. , 2019

Link: https://doi.org/10.1038/..

3

The chromatin remodeler RSF1 controls centromeric histone m..:

Lee, Ho-Soo ; Lin, Zhonghui ; Chae, Sunyoung...
Nature Communications. 9 (2018) 1 - p. , 2018

Link: https://doi.org/10.1038/..

4

Hepatitis B virus X protein activates the ATM–Chk2 pathway ..:

Kim, Sujeong ; Lee, Ho-Soo ; Ji, Jae-Hoon...
Journal of General Virology. 96 (2015) 8 - p. 2242-2251 , 2015

Link: https://doi.org/10.1099/..

5

The chromatin remodeller RSF1 is essential for PLK1 deposit..:

Lee, Ho-Soo ; Park, Yong-Yea ; Cho, Mi-Young...
Nature Communications. 6 (2015) 1 - p. , 2015

Link: https://doi.org/10.1038/..

6

Self-clearance mechanism of mitochondrial E3 ligase MARCH5 ..:

Kim, Song-Hee ; Park, Yong-Yea ; Yoo, Young-Suk.
FEBS Journal. 283 (2015) 2 - p. 294-304 , 2015

Link: https://doi.org/10.1111/..

7

The mitochondrial ubiquitin ligase MARCH5 resolves MAVS agg..:

Yoo, Young-Suk ; Park, Yong-Yea ; Kim, Jae-Hoon...
Nature Communications. 6 (2015) 1 - p. , 2015

Link: https://doi.org/10.1038/..

8

Human mitochondrial Fis1 links to cell cycle regulators at ..:

Lee, Seungmin ; Park, Yong-Yea ; Kim, Song-Hee...
Cellular and Molecular Life Sciences. 71 (2013) 4 - p. 711-725 , 2013

Link: https://doi.org/10.1007/..

9

Phase 2 open-label, multicenter, single-arm study of cemipl..:

Stratigos, Alexander J. ; Sekulic, Aleksandar ; Peris, Ketty...
Journal of the American Academy of Dermatology. 90 (2024) 2 - p. 414-418 , 2024

Link: https://doi.org/10.1016/..

10

Quality of life in cemiplimab-treated patients with locally..:

Stratigos, Alexander J ; Chen, Chieh-I ; Ivanescu, Cristina...
Future Oncology. , 2024

Link: https://doi.org/10.1080/..

11

High response rate with extended dosing of cemiplimab in ad..:

Rischin, Danny ; Hughes, Brett G M ; Basset-Séguin, Nicole...
Journal for ImmunoTherapy of Cancer. 12 (2024) 3 - p. e008325 , 2024

Link: https://doi.org/10.1136/..

12

Phase 2 confirmatory study of cemiplimab (350 mg IV Q3W) in..:

Hughes, Brett ; Grob, Jean-Jacques ; Bowyer, Samantha...
SKIN The Journal of Cutaneous Medicine. 7 (2023) 2 - p. s175 , 2023

Link: https://doi.org/10.25251..

13

Neoadjuvant cemiplimab and surgery for stage II–IV cutaneou..:

Gross, Neil D ; Miller, David M ; Khushalani, Nikhil I...
The Lancet Oncology. 24 (2023) 11 - p. 1196-1205 , 2023

Link: https://doi.org/10.1016/..

14

Phase 2 study of cemiplimab in patients with advanced cutan..:

Migden, Michael ; Schmults, Chrysalyne ; Khushalani, Nikhil...
SKIN The Journal of Cutaneous Medicine. 7 (2023) 2 - p. s176 , 2023

Link: https://doi.org/10.25251..

15

Phase 2 study of cemiplimab in patients with locally advanc..:

Stratigos, Alexander J ; Sekulic, Aleksandar ; Peris, Ketty...
SKIN The Journal of Cutaneous Medicine. 7 (2023) 2 - p. s178 , 2023

Link: https://doi.org/10.25251..